These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6352353)

  • 21. Improved serum insulin profiles in diabetic individuals who massaged their insulin injection sites.
    Dillon RS
    Diabetes Care; 1983; 6(4):399-401. PubMed ID: 6352212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Grand Rounds. Open and closed loop insulin delivery systems in diabetes: current status.
    Service FJ
    Henry Ford Hosp Med J; 1982; 30(3):163-7. PubMed ID: 6761321
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucose-insulin regulation model with subcutaneous insulin injection and evaluation using diabetic inpatients data.
    Wu Z; Chui CK; Hong GS; Khoo E; Chang S
    Comput Methods Programs Biomed; 2013 Aug; 111(2):347-56. PubMed ID: 23756090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of blood sugar in insulin-requiring diabetes.
    N Engl J Med; 1981 Apr; 304(15):908-9. PubMed ID: 7010163
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of heat on insulin absorption: different effects on amorphous and soluble insulins.
    Koivisto VA
    Acta Diabetol Lat; 1983; 20(2):175-8. PubMed ID: 6349204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system.
    Schade DS; Eaton RP; Spencer W; Goldman R; Corbett WT
    Metabolism; 1979 Mar; 28(3):195-7. PubMed ID: 763154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment.
    Micossi P; Raggi U; Dosio F; Scavini M; Bertin A; Pozza G
    J Endocrinol Invest; 1983 Jun; 6(3):189-94. PubMed ID: 6352793
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetic glucose control: matching plasma insulin concentration to dietary and stress hyperglycemia.
    Eaton RP; Spencer W; Schade DS; Shafer BD; Corbett W
    Diabetes Care; 1978; 1(1):40-4. PubMed ID: 400128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insulin delivery systems.
    N Z Med J; 1980 Sep; 92(668):238-9. PubMed ID: 7005766
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin kinetics.
    Kapur A
    J Assoc Physicians India; 1997; Suppl 1():13-7. PubMed ID: 11235628
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison between the plasma insulin and glucose responses to five different insulin regimes in diabetic patients.
    Gokal R; Harding P; Turner RC
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):301-5. PubMed ID: 923108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newer insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Adv Exp Med Biol; 1979; 119():491-5. PubMed ID: 495298
    [No Abstract]   [Full Text] [Related]  

  • 35. New injection recommendations for patients with diabetes.
    Davidson JA
    Diabetes Metab; 2010 Sep; 36 Suppl 2():S2. PubMed ID: 20933207
    [No Abstract]   [Full Text] [Related]  

  • 36. [Home manager wants prescriptions for blood glucose test strips].
    Walbert H
    MMW Fortschr Med; 2015 Nov; 157 Spec No 2():34. PubMed ID: 26953466
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultralente based insulin regimens--clinical applications, advantages and disadvantages.
    Turner RC; Phillips MA; Ward EA
    Acta Med Scand Suppl; 1983; 671():75-86. PubMed ID: 6349269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of insulin delivery with meals.
    Kraegen EW; Chisholm DJ; McNamara ME
    Horm Metab Res; 1981 Jul; 13(7):365-7. PubMed ID: 7024077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial postprandial plasma insulin levels in 117 subjects with and without diabetes.
    Tchobroutsky G; Kopf A; Eschwege E; Assan R
    Diabetes; 1973 Nov; 22(11):825-33. PubMed ID: 4749401
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of glucose values to sliding scale insulin (correctional insulin) dose delivery and meal time in acute care patients with diabetes mellitus.
    Trotter B; Conaway MR; Burns SM
    Medsurg Nurs; 2013; 22(2):99-104, 135. PubMed ID: 23802496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.